You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

anti-VEGF

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage IIIC Lung Cancer AJCC v8 Trial in

Recruiting
  • Metastatic Lung Non-Small Cell Carcinoma
  • +5 more
  • Bevacizumab
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Jul 13, 2022

Macular Degeneration, Age Related, Myopic Choroidal Neovascularisation, Proliferative Diabetic Retinopathy Trial in Perugia

Not yet recruiting
  • Macular Degeneration, Age Related
  • +4 more
  • VISUPRIME
  • Placebo
  • Perugia, PG, Italy
    Ospedale Santa Maria della Misericordia
Dec 22, 2022

Locally Advanced Lung Non-Small Cell Carcinoma, Metastatic Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell

Recruiting
  • Locally Advanced Lung Non-Small Cell Carcinoma
  • +9 more
  • Duarte, California
  • +4 more
Aug 17, 2022

Ovarian Cancer Trial in Houston (Pembrolizumab, Bevacizumab, Cyclophosphamide)

Not yet recruiting
  • Ovarian Cancer
  • Houston, Texas
    MD Anderson Cancer Center
Oct 9, 2023

Macular Degeneration, Wet, Metamorphopsia Trial

Recruiting
  • Macular Degeneration, Wet
  • Metamorphopsia
    • Cuneo, Piedmont, Italy
      Ospedale Santa Croce
    Sep 20, 2022

    Ovarian Cancer Trial in Houston (Paclitaxel, Bevacizumab, Lurbinectedin)

    Not yet recruiting
    • Ovarian Cancer
    • Houston, Texas
      M D Anderson Cancer Center
    Nov 23, 2022

    Anti-VEGF Targeted Drugs on Patients' Blood Pressure and

    Recruiting
    • Cardiac Toxicity
    • +2 more
    • Anti-VEGF
    • Peking, Beijing, China
      Peking University Third Hospital
    Jul 4, 2021

    Intravitreal Injection Site and Perceived Pain

    Recruiting
    • Pain
    • Intravitreal injection site
    • Galveston, Texas
      University of Texas Medical Branch
    Jan 19, 2023

    Metastatic Colon Adenocarcinoma, Metastatic Colorectal Adenocarcinoma, Metastatic Microsatellite Stable Colorectal Carcinoma

    Not yet recruiting
    • Metastatic Colon Adenocarcinoma
    • +6 more
    • Balstilimab
    • +10 more
    • Duarte, California
      City of Hope Medical Center
    Nov 17, 2022

    Cancer Patients Treated With Anti-VEGF-Related Therapies

    Recruiting
    • Hematopoietic and Lymphoid Cell Neoplasm
    • Malignant Solid Neoplasm
    • Electronic Health Record Review
    • Houston, Texas
      M D Anderson Cancer Center
    Oct 25, 2021

    Central Retinal Vein Occlusion With Macular Edema Trial in Peshawar (Group A)

    Completed
    Has Results
    • Central Retinal Vein Occlusion With Macular Edema
    • Group A
    • Peshawar, KPK, Pakistan
      Hayatabad Medical Complex
    Apr 3, 2022

    Cervical Adenocarcinoma, Cervical Adenosarcoma, Cervical Adenosquamous Carcinoma Trial in United States (biological, other,

    Recruiting
    • Cervical Adenocarcinoma
    • +47 more
    • Bevacizumab
    • +3 more
    • Phoenix, Arizona
    • +3 more
    Dec 5, 2022

    Thyroid Eye Disease Trial in Boston (Sub-tenon injection of saline followed by a sub-tenon injection of aflibercept, Sub-tenon

    Recruiting
    • Thyroid Eye Disease
    • Sub-tenon injection of saline followed by a sub-tenon injection of aflibercept
    • +2 more
    • Boston, Massachusetts
      Mass Eye and Ear
    Feb 8, 2022

    Neovascular Age-related Macular Degeneration Trial in Seongnam-si (Probiotic Combination Cap/Tab, intravitreal Anti-VEGF

    Recruiting
    • Neovascular Age-related Macular Degeneration
    • Probiotic Combination Cap/Tab
    • intravitreal Anti-VEGF injection
    • Seongnam-si, Korea, Republic of
      Seoul National University Bundang Hospital
    Nov 1, 2022

    Mucinous Adenocarcinoma of the Rectum, Signet Ring Adenocarcinoma of the Rectum, Stage IIA Rectal Cancer Trial in Los Angeles

    Active, not recruiting
    • Mucinous Adenocarcinoma of the Rectum
    • +7 more
    • bevacizumab
    • +4 more
    • Los Angeles, California
      USC Norris Comprehensive Cancer Center
    Aug 5, 2022

    Liver Cancer Trial in Houston (Bevacizumab, Atezolizumab, Sofosbuvir)

    Not yet recruiting
    • Liver Cancer
    • Houston, Texas
      M D Anderson Cancer Center
    Feb 9, 2023

    Peritoneal Malignant Mesothelioma Trial in United States (biological, drug, procedure)

    Recruiting
    • Peritoneal Malignant Mesothelioma
    • Atezolizumab
    • +8 more
    • Phoenix, Arizona
    • +25 more
    Feb 2, 2023

    Ocular Adverse Events in Neovascular Agerelated Macular

    Completed
    • Age-related Macular Degeneration (AMD)
    • Aflibercept
    • +2 more
    • East Hanover, New Jersey
      Novartis Investigative Site
    Dec 15, 2021

    Aflibercept in Routine Clinical Practice in Diabetic Macular

    Completed
    • Macular Edema
    • Eylea (Aflibercept, VEGF Trap-Eye, BAY86-5321)
    • Anti-VEGF therapies including: Eylea Aflibercept, VEGF Trap-Eye, BAY86-5321) and Ophthalmologicals / Antineovascularisation agents (S01LA05)
    • Multiple Locations, United Kingdom
      (unnamed)
    Nov 1, 2021

    Glioma, Recurrent Glioma Trial in Shanghai (Hypofractionated Stereotactic Radiotherapy, Bevacizumab)

    Active, not recruiting
    • Glioma
    • Recurrent Glioma
    • Shanghai, Shanghai, China
      CyberKnife Center, Department of Neurosurgery, Huashan Hospital
    Nov 3, 2022

    Liver Cancer Trial in Houston (Bevacizumab, Erlotinib)

    Completed
    Has Results
    • Liver Cancer
    • Houston, Texas
      University of Texas MD Anderson Cancer Center
    Nov 3, 2022

    Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube High Grade Serous Adenocarcinoma, Ovarian Endometrioid Adenocarcinoma

    Active, not recruiting
    • Fallopian Tube Endometrioid Adenocarcinoma
    • +7 more
    • Anetumab Ravtansine
    • +2 more
    • Orange, California
    • +22 more
    Oct 22, 2022

    Advanced Malignant Tumor, Castleman Disease, Digestive System Carcinoma Trial in Houston (biological, other, drug)

    Active, not recruiting
    • Advanced Malignant Neoplasm
    • +38 more
    • Bevacizumab
    • +5 more
    • Houston, Texas
      M D Anderson Cancer Center
    Jul 18, 2022

    Maximum Treatment Interval With Aflibercept T&E

    Recruiting
    • Neovascular Age-related Macular Degeneration
    • Aflibercept Injection [Eylea]
    • Taipei, Taiwan
      Shin Kong Memorial Wu Ho-Su Hospital
    Apr 19, 2022

    Genetic Change Trial in Zhengzhou (Gene evolution and molecular response under Bevacizumab treatment)

    Recruiting
    • Genetic Change
    • Gene evolution and molecular response under Bevacizumab treatment
    • Zhengzhou, Henan, China
      Henan Provincial People's Hospital
    Aug 21, 2022